Showing 12,821 - 12,840 results of 113,423 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.87s Refine Results
  1. 12821

    Characteristics of selected studies. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  2. 12822

    The SEYLL rate of countries with available data. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  3. 12823

    Data extraction form. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  4. 12824

    Patterns of SEYLL rate by WHO regions. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  5. 12825

    Distribution of selected studies by country. by Wan Shakira Rodzlan Hasani (9331205)

    Published 2023
    “…Over the past three decades (1990–2022), there has been a slight increase in the YPLL rate and the SEYLL rate for overall CVD and ischemic heart disease but a slight decrease in the SEYLL rate for cerebrovascular disease. …”
  6. 12826

    Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial by Silvana Sekuloski (209827)

    Published 2018
    “…Participants were randomized 4:1 to receive the vaccine candidate (N = 8) or placebo (N = 2). A single dose of the vaccine candidate (MJ8VAX), contained 50 μg of peptide conjugate (J8-DT) adsorbed onto aluminium hydroxide and re-suspended in PBS in a total volume of 0.5 mL. …”
  7. 12827
  8. 12828
  9. 12829
  10. 12830

    P<i><sub>TET</sub></i>-driven OE of 20 genes results in decreased or increased growth rate. A. Impact of OE on the growth rates of 257 OE strains. by Murielle Chauvel (132263)

    Published 2012
    “…Genes in orange correspond to those whose OE decreased growth with a fold equal to 2. Data are mean and SD of 3 experiments. …”
  11. 12831
  12. 12832
  13. 12833

    Table 1_Complex evaluation of coagulation, fibrinolysis, and inflammatory cytokines in SARS-CoV-2 infected pregnant women: a prospective, case-control study.docx by Zsuzsa Bagoly (429210)

    Published 2025
    “…Admission IL-1β, and IL-33 were significantly lower, while IL-18 was significantly higher in cases when COVID-19 became more severe, along with significantly decreased FVIII, FXIII and plasminogen. In the COVID-19+ group, postpartum hemorrhage (PPH) developed in 4 cases, associated with significantly reduced plasminogen, α2-plasmin inhibitor, and increased IL-8, IL-17A, IL-23 levels.…”
  14. 12834

    Dietary Restriction Induces Gluconeogenic Gene <i>pck-2</i> Expression via DAF-16, and <i>pck-2</i> Expression is Needed for DR-associated Healthspan Benefits. by Brian Onken (86790)

    Published 2020
    “…Disrupting glycolytic activity with <i>pfk(RNAi)</i> results in small but significant increases in swimming rates early in life (day 5; <i>P</i> < 0.01, one way ANOVA, a 12% increase) and no later change; glycolytic gene <i>pyk-2(RNAi)</i> did not significantly affect swimming ability on any tested day. …”
  15. 12835
  16. 12836
  17. 12837
  18. 12838
  19. 12839
  20. 12840